India's Pharmaceutical Exports

Country Profile

Benin

Benin is a growing market for Indian pharmaceuticals — $50.8M in FY 2025–26, with 1.7× growth over the past decade. Medicines accounts for 90% of shipments, with vaccines contributing $4.25M. The compound annual growth rate since FY2015 stands at 4.9%.

🇧🇯 $50.8M · 1.7× growth since FY2015 · 4.9% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$50.8M
Exports FY2025–26 DGCIS
1.7×
Growth FY2015→2026
4.9%
CAGR FY2015→2026
90%
Medicines Share
5
Product Categories Supplied
Benin is a growing market for Indian pharmaceuticals — $50.8M in FY 2025–26, with 1.7× growth over the past decade. Medicines accounts for 90% of shipments, with vaccines contributing $4.25M. The compound annual growth rate since FY2015 stands at 4.9%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $45.9M (90.3%) Vaccines $4.25M (8.4%) Surgical & Hospital Supplies $408K (0.8%) Traditional & Herbal $145K (0.3%) Medicine Ingredients $112K (0.2%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Benin in the RBI overseas direct investment dataset (2011–2026).